Skip to main content
. 2021 Apr 30;11:664927. doi: 10.3389/fonc.2021.664927

Figure 1.

Figure 1

RIPK3 expression is reduced in colorectal cancer (CRC) patients. (A) The levels of RIPK3 mRNA expression in colorectal cancer (CRC) and normal colorectal (NC) tissues in the TCGA colorectal database. n, sample numbers. (B) The levels of RIPK3 mRNA expression in different stages of CRC progression. (C) The levels of RIPK3 mRNA expression in metastatic tumors and normal counterparts. (D) Kaplan- Meier analyses of RIPK3 expression in colorectal cancer patients. *p < 0.05.